Span-America Medical Systems, Inc. (SPAN) Stock Analysis
DELISTED 2017
What happened to Span-America Medical Systems, Inc. (SPAN) stock?
Span-America Medical Systems, Inc. (SPAN) no longer trades on public markets. It was delisted in June 2017. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Span-America Medical Systems, Inc. (SPAN) trades at $29.99. Span-America Medical Systems, Inc. specializes in the design and manufacture of pressure management surfaces and other medical products. Sector: Healthcare.
Last analyzed: Mar 16, 2026Analyst Coverage for SPAN: SPAN does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SPAN against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Span-America Medical Systems, Inc. (SPAN) Healthcare & Pipeline Overview
Span-America Medical Systems, Inc. focuses on manufacturing and distributing pressure management surfaces and related medical products for the healthcare sector. The company's products are designed to enhance patient comfort and caregiver efficiency, positioning it as a key player in specialized medical equipment.
What Is the Investment Thesis for SPAN?
Span-America Medical Systems, Inc. presents a focused investment opportunity within the medical equipment sector. The company's specialization in pressure management surfaces caters to a growing need in healthcare, driven by an aging population and increasing awareness of pressure ulcer prevention. With a P/E ratio of 19.31 and a profit margin of 6.3%, Span-America demonstrates stable profitability. Key value drivers include continued product innovation, expansion into new markets, and strategic partnerships with healthcare providers. However, potential risks include competition from larger medical device manufacturers and fluctuations in healthcare spending. Investors should monitor the company's ability to maintain its gross margin of 32.9% and effectively manage its operating expenses.
Based on FMP financials and quantitative analysis
SPAN Key Highlights
P/E ratio of 19.31 indicates a potentially reasonable valuation compared to earnings.
- Profit Margin of 6.3% reflects the company's ability to generate profit from its revenue.
- Gross Margin of 32.9% shows the profitability of Span-America's products after accounting for the cost of goods sold.
- Beta of 0.29 suggests the stock is less volatile than the overall market.
- Span-America operates in the specialized medical equipment market, focusing on pressure management surfaces.
Who Are SPAN's Competitors?
What Are SPAN's Key Strengths?
Specialized expertise in pressure management.
- Established relationships with healthcare providers.
- Innovative product development.
- Strong brand reputation.
What Are SPAN's Weaknesses?
Limited product diversification.
- Reliance on a specific market segment.
- Smaller scale compared to larger competitors.
- Geographic concentration.
What Could Drive SPAN Stock Higher?
SPAN catalyst: New product launches in the pressure management surface category are expected to drive revenue growth.
- Increasing awareness of pressure ulcer prevention is expected to boost demand for Span-America's products.
- Strategic partnerships with healthcare providers are anticipated to expand market reach.
What Are the Key Risks for SPAN?
Competition from larger medical device manufacturers could erode market share.
- Changes in healthcare regulations and reimbursement policies may impact profitability.
- Economic downturns could reduce healthcare spending and demand for Span-America's products.
What Are the Growth Opportunities for SPAN?
- Expansion into international markets presents a significant growth opportunity for Span-America. By leveraging its existing product portfolio and adapting to local market needs, the company can tap into new revenue streams in regions with growing healthcare expenditures. Timeline: Ongoing.
- Developing strategic partnerships with healthcare providers and distributors can enhance Span-America's market reach and penetration. Collaborating with key stakeholders can facilitate product adoption and drive sales growth. Timeline: Ongoing.
- Investing in research and development to create innovative pressure management solutions can differentiate Span-America from its competitors. Developing new products with enhanced features and benefits can attract new customers and retain existing ones. Timeline: Ongoing.
- Expanding the product line to include complementary medical devices and accessories can increase Span-America's revenue per customer. Offering a broader range of products can make the company a more comprehensive supplier to healthcare facilities. Timeline: Ongoing.
- Leveraging digital marketing and e-commerce channels can improve Span-America's brand awareness and accessibility. By reaching a wider audience online, the company can generate new leads and drive sales growth. Timeline: Ongoing.
What Are SPAN's Competitive Advantages?
- Specialized expertise in pressure management surfaces.
- Established reputation for quality and innovation.
- Strong relationships with healthcare providers and distributors.
- Proprietary technology and patents.
What Does SPAN Do?
Span-America Medical Systems, Inc. is a manufacturer of pressure management surfaces and other specialty medical products designed to improve patient outcomes and caregiver efficiency. Founded with a commitment to innovation and quality, the company has evolved into a trusted provider of support surfaces for healthcare environments. Span-America's product line includes therapeutic mattresses, mattress overlays, and wheelchair cushions, all engineered to reduce the risk of pressure ulcers and enhance patient comfort. The company also offers a range of bariatric products and fall prevention solutions. Span-America distributes its products through a network of dealers and directly to healthcare facilities, serving hospitals, nursing homes, and home healthcare providers. With a focus on research and development, Span-America continues to introduce new and improved products that meet the evolving needs of the healthcare industry. The company's commitment to quality and innovation has established it as a key player in the pressure management market.
What Products and Services Does SPAN Offer?
- Design and manufacture pressure management surfaces.
- Produce therapeutic mattresses for hospitals and nursing homes.
- Offer mattress overlays for enhanced patient comfort.
- Develop wheelchair cushions to prevent pressure ulcers.
- Provide bariatric products for overweight patients.
- Create fall prevention solutions for healthcare facilities.
- Distribute products through dealers and direct sales.
How Does SPAN Make Money?
- Manufacturing and selling pressure management surfaces and related medical products.
- Generating revenue through direct sales to healthcare facilities and distributors.
- Investing in research and development to innovate and improve products.
- Providing customer support and training to healthcare providers.
What Industry Does SPAN Operate In?
Span-America Medical Systems, Inc. operates within the medical equipment industry, which is characterized by continuous innovation and increasing demand for advanced healthcare solutions. The market for pressure management surfaces is driven by the rising prevalence of pressure ulcers and the growing geriatric population. Competition includes both large medical device manufacturers and smaller specialized companies. Span-America's focus on pressure management and its established reputation position it well to capitalize on the industry's growth.
Who Are SPAN's Key Customers?
- Hospitals
- Nursing homes
- Home healthcare providers
- Rehabilitation centers
Company Profile
Span-America Medical Systems, Inc. operates in the Medical - Equipment & Services industry within the Healthcare sector. SPAN has traded publicly since 1990.
Key Financial Metrics
Return on equity for Span-America Medical Systems, Inc. stands at 16.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 12.7%, showing how much profit it generates from its asset base. SPAN trades at a trailing price-to-earnings ratio of 19.31, below the Healthcare sector average of ~23x. A current ratio of 3.44 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.2%, the inverse of the P/E and a quick read on earnings relative to price.
SPAN Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Specialized expertise in pressure management.
- Established relationships with healthcare providers.
- Innovative product development.
- Strong brand reputation.
Bear Case
- Limited product diversification.
- Reliance on a specific market segment.
- Smaller scale compared to larger competitors.
- Geographic concentration.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
SPAN Latest News
No recent news available for SPAN.
Who Are SPAN's Competitors?
Span-America Medical Systems, Inc. ADR Information Sponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. SPAN, as an ADR, allows U.S. investors to invest in Span-America Medical Systems, Inc. more conveniently without the complexities of cross-border transactions. It simplifies trading, dividend collection, and reporting for U.S. investors.
- Home Market Ticker: Unknown
- ADR Level: 2
- ADR Ratio: 1:1
SPAN Healthcare Stock FAQ
What happened to Span-America Medical Systems, Inc. (SPAN) stock?
Span-America Medical Systems, Inc. (SPAN) no longer trades on public markets. It was delisted in June 2017. The figures below are historical and are not a current quote.
Can I still buy SPAN shares?
No. SPAN stopped trading on public markets in June 2017, so the shares are not available through a broker. Anything you see quoted for SPAN elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before SPAN stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Span-America Medical Systems, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Span-America Medical Systems, Inc. do?
Span-America Medical Systems, Inc. specializes in the design, manufacture, and marketing of pressure management surfaces and other specialty medical products. These products are primarily used in healthcare settings such as hospitals, nursing homes, and rehabilitation centers. The company's offerings include therapeutic mattresses, mattress overlays, and wheelchair cushions designed to prevent and treat pressure ulcers, enhancing patient comfort and caregiver efficiency.
What are the main risks for SPAN?
Span-America Medical Systems, Inc. faces several risks, including competition from larger medical device manufacturers with greater resources and broader product portfolios. Changes in healthcare regulations and reimbursement policies could negatively impact the demand for its products. Economic downturns may lead to reduced healthcare spending, affecting the company's revenue. Additionally, technological advancements could render existing products obsolete, requiring continuous innovation and investment in research and development.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- AI analysis is pending and may provide additional insights.